‘Reckless’ 280E gamble backfires as feds demand millions from cannabis MSO
In a troubling sign for cannabis operators that claimed 280E relief before rescheduling, the IRS wants TerrAscend USA…
News May 20In a troubling sign for cannabis operators that claimed 280E relief before rescheduling, the IRS wants TerrAscend USA…
News May 20It's not yet known whether DEA registration will be mandatory for benefits like 280E relief, but for medical…
News May 13Medical marijuana manufacturers in Oklahoma will be required to register with the DEA to keep their state permits,…
News May 12The tax implications of medical cannabis rescheduling aren't yet fully known, but cannabis businesses can take action now.
News May 8With rescheduling, investors and financial institutions that worried about the stigma surrounding marijuana are taking another look.
News April 30States are reacting to federal marijuana rescheduling mostly cautiously, but the policy could have some unintended consequences in…
News April 28The Trump administration's historic marijuana rescheduling move is good news for the cannabis industry's tax fight. But 280E…
News April 24Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
News April 23In the biggest shift in federal drug policy in the U.S. since 1970, President Donald Trump's Justice Department…
News April 23